Abeona Therapeutics (ABEO) News Today → Have You Seen Elon’s New A.I. Device? (Picture Inside) (From InvestorPlace) (Ad) Free ABEO Stock Alerts $3.91 -0.23 (-5.56%) (As of 05/1/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investorsbusinesswire.com - May 1 at 8:32 PMAbeona Therapeutics Inc (NASDAQ:ABEO) Director Faith L. Charles Buys 7,550 Sharesamericanbankingnews.com - April 30 at 4:24 AMAbeona Therapeutics Inc (NASDAQ:ABEO) CEO Vishwas Seshadri Purchases 10,000 Sharesamericanbankingnews.com - April 30 at 4:24 AMAbeona Therapeutics Inc (NASDAQ:ABEO) Director Buys $24,764.00 in Stockinsidertrades.com - April 30 at 4:23 AMThe Law Offices of Frank R. Cruz Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investorsbusinesswire.com - April 29 at 7:11 PMAbeona Therapeutics Inc (NASDAQ:ABEO) Director Faith L. Charles Purchases 7,550 Sharesmarketbeat.com - April 29 at 10:27 AMAbeona Therapeutics Inc Expected to Earn Q1 2024 Earnings of ($0.47) Per Share (NASDAQ:ABEO)americanbankingnews.com - April 29 at 1:24 AMJoseph Walter Vazzano Buys 5,608 Shares of Abeona Therapeutics Inc (NASDAQ:ABEO) Stockamericanbankingnews.com - April 28 at 6:04 AMBrendan M. O'malley Purchases 8,600 Shares of Abeona Therapeutics Inc (NASDAQ:ABEO) Stockamericanbankingnews.com - April 28 at 5:30 AMInsider Buying: Abeona Therapeutics Inc (NASDAQ:ABEO) CFO Acquires 5,608 Shares of Stockinsidertrades.com - April 27 at 7:15 AMAbeona Therapeutics Inc (NASDAQ:ABEO) SVP Brendan M. O'malley Acquires 8,600 Sharesinsidertrades.com - April 27 at 7:15 AMAbeona Therapeutics Inc to Post FY2024 Earnings of ($2.38) Per Share, Cantor Fitzgerald Forecasts (NASDAQ:ABEO)americanbankingnews.com - April 27 at 4:04 AMFY2024 EPS Estimates for Abeona Therapeutics Inc Cut by Analyst (NASDAQ:ABEO)marketbeat.com - April 26 at 9:46 AMABEO: Receives CRL Based on Need for More CMC Information…finance.yahoo.com - April 25 at 8:51 PMAbeona Therapeutics (NASDAQ:ABEO) Receives Overweight Rating from Cantor Fitzgeraldamericanbankingnews.com - April 24 at 5:48 AMAbeona Therapeutics Tanks On CRL From The FDA, But All Hope Is Not Lostseekingalpha.com - April 23 at 9:43 PMAbeona Therapeutics Inc.: Abeona Therapeutics Provides Regulatory Update on Pz-celfinanznachrichten.de - April 23 at 4:42 PMFDA Rejects Approval Of Abeona Therapeutics' Skin Disorder Treatment, Shares Sinkmsn.com - April 23 at 11:41 AMCantor Fitzgerald Reaffirms Overweight Rating for Abeona Therapeutics (NASDAQ:ABEO)marketbeat.com - April 23 at 9:16 AMWhy Is Abeona Therapeutics (ABEO) Stock Down 45% Today?investorplace.com - April 23 at 8:53 AMAbeona Therapeutics (NASDAQ:ABEO) Shares Cross Below 50 Day Moving Average of $7.49americanbankingnews.com - April 23 at 5:34 AMAbeona Therapeutics (NASDAQ:ABEO) Downgraded to Sell at StockNews.comamericanbankingnews.com - April 23 at 2:14 AMAbeona Therapeutics Shares Down 53% After FDA Complete Response Lettermarketwatch.com - April 22 at 11:19 PMUS FDA declines to approve Abeona's skin disorder treatmentreuters.com - April 22 at 4:31 PMAbeona Therapeutics Provides Regulatory Update on Pz-celglobenewswire.com - April 22 at 4:05 PMmarketbeat.com - April 22 at 4:04 PMAbeona Therapeutics (NASDAQ:ABEO) Upgraded by StockNews.com to "Hold"marketbeat.com - April 15 at 11:09 PMAbeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - April 1 at 8:30 AMHere's Why We're Not Too Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Situationfinance.yahoo.com - March 27 at 10:27 AMAnalysts Issue Forecasts for Abeona Therapeutics Inc's FY2024 Earnings (NASDAQ:ABEO)marketbeat.com - March 22 at 8:35 AMABEO Stock Earnings: Abeona Therapeutics Misses EPS for Q4 2023investorplace.com - March 19 at 7:06 AMQ4 2023 Abeona Therapeutics Inc Earnings Callfinance.yahoo.com - March 19 at 6:53 AMAbeona Therapeutics Inc (ABEO) Reports Full Year 2023 Financial Resultsfinance.yahoo.com - March 19 at 6:53 AMInventiva Phase 2 study for MASH drug meets primary endpointmsn.com - March 18 at 7:34 PMAbeona Therapeutics Shares Drop 13% After FDA Inspection of Cleveland Facilitymarketwatch.com - March 18 at 7:34 PMAbeona Therapeutics Inc.: Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspectionsfinanznachrichten.de - March 18 at 2:07 PMAbeona Therapeutics GAAP EPS of -$2.53, revenue of $3.5Mmsn.com - March 18 at 2:07 PMAbeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspectionsglobenewswire.com - March 18 at 7:30 AMABEO Dec 2024 15.000 callfinance.yahoo.com - March 16 at 9:20 AM153,930 Shares in Abeona Therapeutics Inc (NASDAQ:ABEO) Purchased by Schonfeld Strategic Advisors LLCmarketbeat.com - March 12 at 5:17 AMAbeona Therapeutics (NASDAQ: ABEO)fool.com - March 10 at 12:10 PMSeveral Insiders Invested In Abeona Therapeutics Flagging Positive Newsfinance.yahoo.com - March 10 at 12:10 PMAdage Capital Partners GP L.L.C. Has $13.68 Million Stake in Abeona Therapeutics Inc (NASDAQ:ABEO)marketbeat.com - March 9 at 6:35 AMWorth Venture Partners LLC Acquires 121,969 Shares of Abeona Therapeutics Inc (NASDAQ:ABEO)marketbeat.com - March 6 at 12:57 PMAbeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - March 5 at 7:30 AMAbeona Therapeutics Inc (NASDAQ:ABEO) Shares Acquired by Citigroup Inc.marketbeat.com - February 25 at 4:41 AMAbeona Therapeutics Stock (NASDAQ:ABEO), Short Interest Reportbenzinga.com - February 22 at 5:57 AMAbeona Therapeutics Stock (NASDAQ:ABEO) Insider Tradesbenzinga.com - February 21 at 10:40 PMAbeona Therapeutics Incmoney.usnews.com - February 20 at 11:28 AMAbeona Therapeutics (NASDAQ:ABEO) Downgraded by StockNews.com to "Sell"marketbeat.com - February 19 at 11:15 PM Get Abeona Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter. Email Address READ THIS – If You Missed Out On The AI Boom (Ad)Adam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.” Click on Adam's shiny forehead for more details. ABEO Media Mentions By Week ABEO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABEO News Sentiment▼0.600.35▲Average Medical News Sentiment ABEO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABEO Articles This Week▼242▲ABEO Articles Average Week Get Abeona Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ProPhase Labs News Genelux News PMV Pharmaceuticals News Allakos News DiaMedica Therapeutics News SELLAS Life Sciences Group News Oramed Pharmaceuticals News BioXcel Therapeutics News Milestone Pharmaceuticals News IO Biotech News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ABEO) was last updated on 5/1/2024 by MarketBeat.com Staff From Our PartnersHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace😱 This phenomenon is smashing regular market gainsMillPubDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingTrump just won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abeona Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
